SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-19-006106
Filing Date
2019-02-06
Accepted
2019-02-06 17:13:53
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 a19-4000_1s3.htm S-3 411319
2 EX-5.1 a19-4000_1ex5d1.htm EX-5.1 34332
3 EX-23.2 a19-4000_1ex23d2.htm EX-23.2 3867
4 GRAPHIC g40001kgi001.jpg GRAPHIC 2552
5 GRAPHIC g40001bei001.jpg GRAPHIC 7560
  Complete submission text file 0001104659-19-006106.txt   464721
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-229534 | Film No.: 19572319
SIC: 2834 Pharmaceutical Preparations